Type 2 Diabetes Trial, Not Yet Recruiting NCT07663123 Sponsor: Institute for Human Development and Potential (IHDP), Singapore Condition: Type 2 Diabetes
Back to Type 2 Diabetes

Type 2 Diabetes Trial, Not Yet Recruiting

NCT07663123
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • Men or women between 40 and 65 years old
  • Of Chinese, Malay, or Indian ethnicity
  • Having a Body Mass Index (a measure of body weight relative to height) between 23.0 and 32.0
  • Having blood sugar levels that suggest prediabetes, based on specific fasting blood glucose and HbA1c (a 3-month average blood sugar measure) test results
  • Usually eating around 3 to 5 servings of polished white rice per day
  • Having no known food allergies or intolerances to the foods that will be provided as part of the study
  • Able to read and communicate proficiently in English
  • Willing to follow the study procedures and sign a written consent form

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have been diagnosed with Type 1 or Type 2 diabetes, or who do not pass a specific blood sugar test (OGTT) during the screening visit
  • People with a history of, or current diagnosis of, heart, hormonal, digestive, blood, liver (hepatitis B or C), kidney, cancer (except a minor skin cancer type called basal cell carcinoma), or other conditions that the study team determines may affect the results
  • People currently taking ongoing medications (such as metformin or oral steroids) or supplements that the study team determines may affect blood sugar levels or other study results
  • People who have had weight-loss (bariatric) surgery in the past
  • People whose body weight has changed by more than 5% in the last 3 months
  • Women who are currently pregnant, breastfeeding, or planning to become pregnant
  • People who have used illegal drugs within the last 5 years
  • People who drink more than 2 alcoholic drinks per day
  • People who have smoked in the last 1 year
  • People currently following a special diet (such as a ketogenic diet, intermittent fasting, or a calorie-restricted diet) that may interfere with study results
  • People who have made major changes to their physical activity or eating habits in the last 3 months
  • People who have taken oral antibiotics in the last 3 months
  • People currently taking part in another intervention study that the study team determines may affect results
  • Staff members of IHDP and SIFBI at A*STAR

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 10 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Johan G. Eriksson, MD, A*STAR Institute for Human Development and Potential (A*STAR IHDP)

Phone: +65 6407 0100

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
Institute for Human Development and Potential (IHDP), Singapore
Registry
ClinicalTrials.gov
Start date
10 August 2026
Est. completion
30 April 2029

Primary endpoints

Change in Haemoglobin A1c (HbA1c) levels

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 10 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov